Serum Ferritin and Gestational Diabetes: A Growing Concern

Gestational diabetes mellitus (GDM), a glucose metabolism disorder specific to pregnancy, is a rising global health concern. Recent research increasingly points to a link between serum ferritin levels – a marker of iron storage – and the risk of developing GDM. While elevated ferritin has been suggested to increase GDM risk, large-scale studies are now providing more compelling evidence and prompting a closer look at the underlying mechanisms.

The Rising Prevalence of Gestational Diabetes

By 2024, the global prevalence of GDM was estimated at 15.6%, with China reporting a similar rate of 15.7% [1]. GDM carries both short-term and long-term risks. In the short term, it can lead to complications like preeclampsia, cesarean delivery, and neonatal hypoglycemia. Long-term consequences include increased risks of obesity, type 2 diabetes, and cardiovascular disease for both mothers and their children [1].

The Role of Iron and Ferritin

Iron is essential for numerous bodily functions, including oxygen transport and cell proliferation. Iron deficiency is common during pregnancy, affecting up to 80% of women in low- and middle-income countries [2]. However, accumulating evidence suggests that excess iron storage may also be detrimental, potentially contributing to insulin resistance and increasing the risk of type 2 diabetes in non-pregnant individuals [2]. Ferritin, as the primary indicator of iron status, is therefore a key area of investigation.

Recent Research Findings

A recent prospective cohort study involving 6,614 pregnant women conducted across China revealed significant associations between serum ferritin levels in the first and second trimesters and GDM risk [3]. The study found a U-shaped relationship between ferritin levels at 11-13 weeks of gestation and GDM risk, meaning that both very low and very high levels were associated with increased risk [3]. Specifically, women in the highest tertile of serum ferritin at 16–19 weeks’ gestation (RR: 1.28; 95% CI: 1.03, 1.58) and 24–27 weeks’ gestation (RR: 1.18; 95% CI: 1.03, 1.35) had a significantly greater GDM risk compared with the middle tertile [3].

Another study, published in March 2025, reinforced the correlation between excess iron and GDM development [2]. Research from 2006 indicated that elevated serum ferritin levels are associated with an increased risk of GDM [4].

Implications for Clinical Practice

These findings suggest that measuring serum ferritin levels during the first and second trimesters could potentially aid identify women at higher risk of developing GDM. However, researchers emphasize that more research is needed to fully understand the mechanisms underlying this association and to determine the clinical utility of ferritin measurements for early identification and prevention [1].

Key Takeaways

• GDM is a growing global health concern with significant short- and long-term consequences.
• Elevated serum ferritin levels, a marker of iron storage, are increasingly linked to an increased risk of GDM.
• Recent studies demonstrate a U-shaped relationship between ferritin levels and GDM risk, with both very low and very high levels being associated with increased risk.
• Further research is needed to clarify the mechanisms involved and to determine how ferritin measurements can be used in clinical practice to identify and prevent GDM.